Suzana M. Lobo
Hospital de Base
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Suzana M. Lobo.
Critical Care Medicine | 2000
Suzana M. Lobo; Paula F. Salgado; Vania G. T. Castillo; Aldenis A. Borim; Carlos A Polachini; José C. Palchetti; Sergio L. A. Brienzi; Granville G. De Oliveira
ObjectiveTo evaluate the effects of maximizing the oxygen delivery on morbidity and mortality in patients >60 yrs of age and/or with chronic diseases of vital organs who underwent major elective surgery. DesignProspective, randomized, controlled trial. SettingA 24-bed general intensive care unit of a teaching hospital. PatientsThirty-seven high-risk patients who underwent major surgery. InterventionsThe hemodynamic and oxygen transport variables and outcomes in 18 patients (control group) treated to maintain normal values of oxygen delivery were compared with 19 patients (protocol group) treated to maintain “supranormal” values. Therapy in both groups consisted of volume expansion and, when necessary, dobutamine to reach target values, during the surgery and 24 hrs postoperatively. Measurements and Main ResultsWe interrupted the study because of a significant difference in the 60-day mortality rate. The mortality rate in the control group was significantly higher when compared with the protocol group (9/18 [50%] vs. 3/19 [15.7%], p < .05). The prevalence of clinical and infectious complications was higher in the control group than in the protocol group (67% and 31% respectively; relative risk, 0.47; 95% confidence interval, 0.226–0.991;p < .05) and there was a trend toward more severe organ dysfunction in nonachievers patients (17/24 [71%] vs. 6/13 [46%], relative risk, 0.65; 95% confidence interval, 0.343–1.237; NS). ConclusionOlder patients with existing cardiorespiratory illness undergoing major surgery have a reduced morbidity and mortality when dobutamine is used to maximize oxygen transport.
Critical Care Medicine | 2010
Márcio Soares; Pedro Caruso; Eliezer Silva; José Mario Meira Teles; Suzana M. Lobo; Gilberto Friedman; Felipe Dal Pizzol; Patrícia Veiga C Mello; Fernando A. Bozza; Ulisses V. A. Silva; André P. Torelly; Marcos Freitas Knibel; Ederlon Rezende; José J. Netto; Claudio Piras; Aline Castro; Bruno S. Ferreira; Álvaro Réa-Neto; Patrícia B. Olmedo; Jorge I. F. Salluh
Objective:To evaluate the characteristics and outcomes of patients with cancer admitted to several intensive care units. Knowledge on patients with cancer requiring intensive care is mostly restricted to single-center studies. Design:Prospective, multicenter, cohort study. Setting:Intensive care units from 28 hospitals in Brazil. Patients:A total of 717 consecutive patients included over a 2-mo period. Interventions:None. Measurements and Main Results:There were 667 (93%) patients with solid tumors and 50 (7%) patients had hematologic malignancies. The main reasons for intensive care unit admission were postoperative care (57%), sepsis (15%), and respiratory failure (10%). Overall hospital mortality rate was 30% and was higher in patients admitted because of medical complications (58%) than in emergency (37%) and scheduled (11%) surgical patients (p < .001). Adjusting for covariates other than the type of admission, the number of hospital days before intensive care unit admission (odds ratio [OR], 1.18; 95% confidence interval [CI], 1.01–1.37), higher Sequential Organ Failure Assessment scores (OR, 1.25; 95% CI, 1.17–1.34), poor performance status (OR, 3.40; 95% CI, 2.19 –5.26), the need for mechanical ventilation (OR, 2.42; 95% CI, 1.51–3.87), and active underlying malignancy in recurrence or progression (OR, 2.42; 95% CI, 1.51–3.87) were associated with increased hospital mortality in multivariate analysis. Conclusions:This large multicenter study reports encouraging survival rates for patients with cancer requiring intensive care. In these patients, mortality was mostly dependent on the severity of organ failures, performance status, and need for mechanical ventilation rather than cancer-related characteristics, such as the type of malignancy or the presence of neutropenia.
Chest | 2014
Luciano C. P. Azevedo; Pedro Caruso; Ulysses V. A. Silva; André P. Torelly; Eliezer Silva; Ederlon Rezende; José J. Netto; Claudio Piras; Suzana M. Lobo; Marcos Freitas Knibel; José Mario Meira Teles; Ricardo. A. Lima; Bruno S. Ferreira; Gilberto Friedman; Álvaro Réa-Neto; Felipe Dal-Pizzol; Fernando A. Bozza; Jorge I. F. Salluh; Márcio Soares
BACKGROUND This study was undertaken to evaluate the clinical characteristics and outcomes of patients with cancer requiring nonpalliative ventilatory support. METHODS This was a secondary analysis of a prospective cohort study conducted in 28 Brazilian ICUs evaluating adult patients with cancer requiring invasive mechanical ventilation (MV) or noninvasive ventilation (NIV) during the first 48 h of their ICU stay. We used logistic regression to identify the variables associated with hospital mortality. RESULTS Of 717 patients, 263 (37%) (solid tumors = 227; hematologic malignancies = 36) received ventilatory support. NIV was initially used in 85 patients (32%), and 178 (68%) received MV. Additionally, NIV followed by MV occurred in 45 patients (53%). Hospital mortality rates were 67% in all patients, 40% in patients receiving NIV only, 69% when NIV was followed by MV, and 73% in patients receiving MV only (P < .001). Adjusting for the type of admission, newly diagnosed malignancy (OR, 3.59; 95% CI, 1.28-10.10), recurrent or progressive malignancy (OR, 3.67; 95% CI, 1.25-10.81), tumoral airway involvement (OR, 4.04; 95% CI, 1.30-12.56), performance status (PS) 2 to 4 (OR, 2.39; 95% CI, 1.24-4.59), NIV followed by MV (OR, 3.00; 95% CI, 1.09-8.18), MV as initial ventilatory strategy (OR, 3.53; 95% CI, 1.45-8.60), and Sequential Organ Failure Assessment score (each point except the respiratory domain) (OR, 1.15; 95% CI, 1.03-1.29) were associated with hospital mortality. Hospital survival in patients with good PS and nonprogressive malignancy and without tumoral airway involvement was 53%. Conversely, patients with poor functional capacity and cancer progression had unfavorable outcomes. CONCLUSIONS Patients with cancer with good PS and nonprogressive disease requiring ventilatory support should receive full intensive care, because one-half of these patients survive. On the other hand, provision of palliative care should be considered the main goal for patients with poor PS and progressive underlying malignancy.
Critical Care | 2006
Suzana M. Lobo; Francisco Ricardo Marques Lobo; Carlos A Polachini; Daniela S Patini; A Yamamoto; Neymar E Oliveira; Patrícia Serrano; Helder S Sanches; Marco A Spegiorin; Márcio Mussolino Queiroz; Antonio C Christiano; Elisangela F Savieiro; Paula A Alvarez; Silvia P Teixeira; Geni Satomi Cunrath
IntroductionPreventing perioperative tissue oxygen debt contributes to a better postoperative recovery. Whether the beneficial effects of fluids and inotropes during optimization of the oxygen delivery index (DO2I) in high-risk patients submitted to major surgeries are due to fluids, to inotropes, or to the combination of the two is not known. We aimed to investigate the effect of DO2I optimization with fluids or with fluids and dobutamine on the 60-day hospital mortality and incidence of complications.MethodsA randomized and controlled trial was performed in 50 high-risk patients (elderly with coexistent pathologies) undergoing major elective surgery. Therapy consisted of pulmonary artery catheter-guided hemodynamic optimization during the operation and 24 hours postoperatively using either fluids alone (n = 25) or fluids and dobutamine (n = 25), aiming to achieve supranormal values (DO2I > 600 ml/minute/m2).ResultsThe cardiovascular depression was an important component in the perioperative period in this group of patients. Cardiovascular complications in the postoperative period occurred significantly more frequently in the volume group (13/25, 52%) than in the dobutamine group (4/25, 16%) (relative risk, 3.25; 95% confidence interval, 1.22–8.60; P < 0.05). The 60-day mortality rates were 28% in the volume group and 8% in the dobutamine group (relative risk, 3.00; 95% confidence interval, 0.67–13.46; not significant).ConclusionIn patients with high risk of perioperative death, pulmonary artery catheter-guided hemodynamic optimization using dobutamine determines better outcomes, whereas fluids alone increase the incidence of postoperative complications.
Chest | 2014
Luciano C. P. Azevedo; Pedro Caruso; Ulysses V. A. Silva; André P. Torelly; Eliezer Silva; Ederlon Rezende; José J. Netto; Claudio Piras; Suzana M. Lobo; Marcos Freitas Knibel; José Mario Meira Teles; Ricardo. A. Lima; Bruno S. Ferreira; Gilberto Friedman; Álvaro Réa-Neto; Felipe Dal-Pizzol; Fernando A. Bozza; Jorge I. F. Salluh; Márcio Soares
BACKGROUND This study was undertaken to evaluate the clinical characteristics and outcomes of patients with cancer requiring nonpalliative ventilatory support. METHODS This was a secondary analysis of a prospective cohort study conducted in 28 Brazilian ICUs evaluating adult patients with cancer requiring invasive mechanical ventilation (MV) or noninvasive ventilation (NIV) during the first 48 h of their ICU stay. We used logistic regression to identify the variables associated with hospital mortality. RESULTS Of 717 patients, 263 (37%) (solid tumors = 227; hematologic malignancies = 36) received ventilatory support. NIV was initially used in 85 patients (32%), and 178 (68%) received MV. Additionally, NIV followed by MV occurred in 45 patients (53%). Hospital mortality rates were 67% in all patients, 40% in patients receiving NIV only, 69% when NIV was followed by MV, and 73% in patients receiving MV only (P < .001). Adjusting for the type of admission, newly diagnosed malignancy (OR, 3.59; 95% CI, 1.28-10.10), recurrent or progressive malignancy (OR, 3.67; 95% CI, 1.25-10.81), tumoral airway involvement (OR, 4.04; 95% CI, 1.30-12.56), performance status (PS) 2 to 4 (OR, 2.39; 95% CI, 1.24-4.59), NIV followed by MV (OR, 3.00; 95% CI, 1.09-8.18), MV as initial ventilatory strategy (OR, 3.53; 95% CI, 1.45-8.60), and Sequential Organ Failure Assessment score (each point except the respiratory domain) (OR, 1.15; 95% CI, 1.03-1.29) were associated with hospital mortality. Hospital survival in patients with good PS and nonprogressive malignancy and without tumoral airway involvement was 53%. Conversely, patients with poor functional capacity and cancer progression had unfavorable outcomes. CONCLUSIONS Patients with cancer with good PS and nonprogressive disease requiring ventilatory support should receive full intensive care, because one-half of these patients survive. On the other hand, provision of palliative care should be considered the main goal for patients with poor PS and progressive underlying malignancy.
PharmacoEconomics | 2008
Ana M. C. Sogayar; Flávia Ribeiro Machado; Álvaro Réa-Neto; Amselmo Dornas; Cintia Magalhães Carvalho Grion; Suzana M. Lobo; Bernardo R. Tura; C Silva; R Cal; Idal Beer; Vilto Michels; Jorge Safi; Marcia J. Kayath; Eliezer Silva
BackgroundSepsis has a high prevalence within intensive care units, with elevated rates of morbidity and mortality, and high costs. Data on sepsis costs are scarce in the literature, and in developing countries such as Brazil these data are largely unavailable.ObjectivesTo assess the standard direct costs of sepsis management in Brazilian intensive care units (ICUs) and to disclose factors that could affect those costs.MethodsThis multicentre observational cohort study was conducted in adult septic patients admitted to 21 mixed ICUs of private and public hospitals in Brazil from 1 October 2003 to 30 March 2004. Complete data for all patients admitted to the ICUs were obtained until their discharge or death. We collected only direct healthcare-related costs, defined as all costs related to the ICU stay.Enrolled patients were assessed daily in terms of cost-related expenditures such as hospital fees, operating room fees, gas therapy, physiotherapy, blood components transfusion, medications, renal replacement therapy, laboratory analysis and imaging. Standard unit costs (year 2006 values) were based on the Brazilian Medical Association (AMB) price index for medical procedures and the BRASINDICE price index for medications, solutions and hospital consumables. Medical resource utilization was also assessed daily using the Therapeutic Intervention Scoring System (TISS-28). Indirect costs were not included.ResultsWith a mean (standard deviation [SD]) age of 61.1 ± 19.2 years, 524 septic patients from 21 centres were included in this study. The overall hospital mortality rate was 43.8%, the mean Acute Physiology And Chronic Health Evaluation II (APACHE II) score was 22.3 ± 5.4, and the mean Sequential Organ Failure Assessment (SOFA) score at ICU admission was 7.5 ± 3.9.The median total cost of sepsis was
Critical Care | 2012
Yasser Sakr; Suzana M. Lobo; Rui Moreno; Herwig Gerlach; V. Marco Ranieri; Argyris Michalopoulos; Jean Louis Vincent
US9632 (interquartile range [IQR] 4583–18 387; 95% CI 8657, 10 672) per patient, while the median daily ICU cost per patient was
Anesthesia & Analgesia | 2011
Suzana M. Lobo; Ederlon Rezende; Marcos Freitas Knibel; Nilton Brandão da Silva; José Antonio Matos Páramo; Flávio Eduardo Nácul; Ciro Leite Mendes; Murilo Santucci Assunção; Rubens C. Costa; Cintia Magalhães Carvalho Grion; Sérgio Félix Pinto; Patricia M. Mello; Marcelo de Oliveira Maia; Péricles Almeida Delfino Duarte; Fernando Gutierrez; João Marcelo Silva; Marcell R. Lopes; José Antônio Cordeiro; Charles Mellot
US934 (IQR 735–1170; 95% CI 897, 963). The median daily ICU cost per patient was significantly higher in non-survivors than in survivors, i.e.
Journal of Critical Care | 2009
Jorge I. F. Salluh; Felipe Dal-Pizzol; Patrícia Veiga C Mello; Gilberto Friedman; Eliezer Silva; José Mário Meira Teles; Suzana M. Lobo; Fernando A. Bozza; Márcio Soares
US1094 (IQR 888–1341; 95% CI 1058, 1157) and
International Journal of Antimicrobial Agents | 2009
Anthony Holley; Joel M. Dulhunty; Stijn Blot; Jeffrey Lipman; Suzana M. Lobo; Craig Dancer; Jordi Rello; George Dimopoulos
US826 (IQR 668–982; 95% CI 786, 854), respectively (p < 0.001). For patients admitted to public and private hospitals, we found a median SOFA score at ICU admission of 7.5 and 7.1, respectively (p = 0.02), and the mortality rate was 49.1% and 36.7%, respectively (p = 0.006). Patients admitted to public and private hospitals had a similar length of stay of 10 (IQR 5–19) days versus 9 (IQR 4–16) days (p = 0.091), and the median total direct costs for public (